NCT06539468 2026-04-14
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
University of Michigan Rogel Cancer Center
Phase NA Recruiting
Clinical Trials
62 trialsNCT06745024 2026-04-08
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
NRG Oncology
Phase 3 Active not recruiting
NCT05812807 2026-04-07
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT05976763 2026-04-07
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT07513389 2026-04-07
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Medical University of South Carolina
Phase 2 Not yet recruiting
NCT05873608 2026-04-06
Communication Issues in Patient and Provider Discussions of Immunotherapy
Emory University
Phase NA Recruiting
NCT02135042 2026-04-03
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
Phase 2/3 Active not recruiting
NCT07281547 2026-02-18
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Mayo Clinic
Phase 4 Not yet recruiting
NCT07405476 2026-02-12
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Phase 2 Not yet recruiting
NCT03516617 2026-02-09
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Phase 2 Recruiting
NCT05333874 2026-02-09
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Active not recruiting
NCT06733350 2026-02-09
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Suspended
NCT07370675 2026-01-27
Active Surveillance for Bethesda IV Thyroid Nodules
Rigshospitalet, Denmark
Phase NA Recruiting
NCT05710406 2026-01-26
Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer
Alliance for Clinical Trials in Oncology
Phase 2/3 Active not recruiting
NCT07025226 2026-01-26
Senolytics
Mayo Clinic
Phase EARLY_PHASE1 Recruiting
NCT02914873 2026-01-20
PCASTT
Uppsala University
Phase NA Active not recruiting
NCT06411938 2026-01-16
Merck-3
Indiana University
Phase NA Active not recruiting
NCT07240220 2026-01-15
Merck-4
Indiana University
Phase NA Not yet recruiting
NCT03180268 2026-01-14
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Phase 3 Recruiting
NCT06378866 2025-12-26
DIVINE
Mayo Clinic
Phase 2 Recruiting
NCT03803553 2025-12-23
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Massachusetts General Hospital
Phase 3 Recruiting
NCT03594630 2025-11-06
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT04519879 2025-10-29
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
City of Hope Medical Center
Phase 2 Active not recruiting
NCT02882282 2025-10-23
Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06200103 2025-09-11
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
Phase 2 Recruiting
NCT02609685 2025-09-09
PMCAS
Cedars-Sinai Medical Center
Phase NA Recruiting
NCT06537154 2025-07-30
NEO-BLAST
University of British Columbia
Phase 2/3 Recruiting
NCT07023432 2025-06-17
Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT06998342 2025-05-31
MOHSAHRTSS
University of Vermont Medical Center
Phase 2 Not yet recruiting
NCT06861894 2025-05-15
Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC
Shanghai Chest Hospital
Phase 2 Not yet recruiting
NCT06974370 2025-05-15
ACTION-Brain
University of Vermont Medical Center
Phase 2 Not yet recruiting
NCT04068103 2025-05-07
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
NRG Oncology
Phase 2/3 Active not recruiting
NCT06686381 2025-02-05
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
American University of Beirut Medical Center
Phase 2 Not yet recruiting
NCT01725165 2024-10-24
Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06238648 2024-09-26
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Academic and Community Cancer Research United
Phase 2 Recruiting
NCT05953181 2024-09-19
SANO
Erasmus Medical Center
Phase NA Active not recruiting
NCT00080756 2024-08-28
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
City of Hope Medical Center
Phase 2 Active not recruiting
NCT06089369 2024-04-30
Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion
Tongji Hospital
Phase 3 Not yet recruiting
NCT04029714 2024-02-23
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment
Guy's and St Thomas' NHS Foundation Trust
Phase NA Active not recruiting
NCT04489212 2024-02-08
Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries
Mayo Clinic
Phase NA Completed
NCT03972943 2024-01-08
CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia
University of Utah
Phase EARLY_PHASE1 Terminated
NCT01088750 2023-12-13
EuroNetLP1
Martin-Luther-Universität Halle-Wittenberg
Phase 4 Completed
NCT00887432 2021-10-26
Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Roswell Park Cancer Institute
Phase NA Completed
NCT01085630 2021-08-18
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT04919460 2021-06-09
Research on Optimization and Evaluation of Oral Cancer Screening Methods
Hunan Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT01717677 2021-02-10
PREFERE
Association of Urologic Oncology (AUO)
Phase NA Terminated
NCT00410683 2020-11-20
LUNG ART
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown
NCT01928485 2020-10-22
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT03923777 2020-07-16
ACTION-Lung
University of Vermont Medical Center
Phase NA Unknown
NCT03804320 2020-02-11
Protocol Active Surveillance Small Renal Masses (SRMs)
IRCCS San Raffaele
Phase NA Recruiting